T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 1, 2015 at 4pm EST
Fund Composition
Asset Allocation
as of 04/30/2016
Domestic Stock 94.2%
Foreign Stock 3.9%
Cash 1.4%
Convertibles 0.6%
Foreign Bonds 0.0%
Preferreds 0.0%
Options -0.1%
Volatility and Other Measures
as of 04/30/2016
Beta 0.92
0.37
Standard Deviation 16.91
Price/Earnings Ratio (Domestic) 18.6
Earnings Growth Rate (Domestic) 11.7
Turnover Rate 6.8
Median Market
Capitalization
$34,157.53 Million
Sector Diversification
as of 04/30/2016
% of Total Net Assets
Services 36.0%
Biotechnology 25.2%
Pharmaceuticals 20.2%
Products & Devices 11.0%
Life Sciences 6.4%
10 Largest Holdings
Represents 36.79 % of Total Net Assets
View Holdings as of:
Aetna
Alexion Pharmaceuticals
Allergan
Becton, Dickinson & Company
Bristol-Myers Squibb
Cigna
Humana
McKesson
Thermo Fisher Scientific
UnitedHealth Group
As of 04/30/2016 the Health Sciences Fund had a total of 140 holdings.
See Glossary for additional details on all data elements.